Markus Mäegerlein

Title: The Innovative Contributions of Markus Mäegerlein

Introduction

Markus Mäegerlein is a notable inventor based in Mannheim, Germany. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of formulations that enhance drug bioavailability. His work is characterized by a commitment to improving therapeutic outcomes through innovative solutions.

Latest Patents

One of Markus Mäegerlein's key patents is focused on itraconazole compositions with improved bioavailability. This patent describes a solid dispersion product that comprises itraconazole and hydroxypropyl methylcellulose. The formulation satisfies the specific criteria of Formula 0.35 > ΔH(1), where ΔH represents the endotherm (J/g) accompanying a transition at approximately 240°C. This innovative solid dispersion product demonstrates enhanced bioavailability, which is crucial for effective drug delivery.

Career Highlights

Markus currently works at Abbott GmbH & Co. KG, a leading global healthcare company. His role involves research and development, where he applies his expertise to create advanced pharmaceutical products. His dedication to innovation has positioned him as a valuable asset within the organization.

Collaborations

Throughout his career, Markus has collaborated with several talented professionals, including Gunther Berndl and Matthias Degenhardt. These collaborations have fostered a dynamic environment for innovation and have contributed to the successful development of new pharmaceutical solutions.

Conclusion

Markus Mäegerlein's contributions to the field of pharmaceuticals, particularly through his patent on itraconazole compositions, highlight his innovative spirit and commitment to improving drug formulations. His work continues to impact the industry positively, paving the way for advancements in therapeutic efficacy.